GSK gets US clearance for covid antibody drug to treat 12 years and above
Sotrovimab will be available for appropriate patients diagnosed with COVID-19 in the US in the coming weeks.
Sotrovimab will be available for appropriate patients diagnosed with COVID-19 in the US in the coming weeks.
0 Comments
Post a Comment